Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 8:31 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 241–264 of 1,943 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Context 2 Clear all

Conditions: Diabetes Mellitus, Hypertension
Interventions: NOTES, AUDIO; Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 1,022 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 3
States / cities: Manchester, New Hampshire • Nashville, Tennessee • Galveston, Texas

Conditions: Multiple Myeloma
Interventions: Pomalidomide, Dexamethasone, Daratumumab; Drug
Lead sponsor: Celgene; Industry
Eligibility: 18 Years and older
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2025
U.S. locations: 33
States / cities: Tucson, Arizona • Greenbrae, California • Los Angeles, California + 28 more

Conditions: Spina Bifida
Interventions: PedMMSWC Wheelchair User Testing, PedMMSWC Simulated Home, School, Community Environment; Device
Lead sponsor: Optimal Mobility, Inc; Industry
Eligibility: 8 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Pediatric Obesity, Nutrition Disorder
Interventions: Nourish to Flourish: The Power of Positive Food Parenting; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 5 Years and older
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Albuterol eMDPI DS; Combination Product
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 40 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Winston-Salem, North Carolina

Conditions: Healthy Volunteer
Interventions: Information absent, Information; Other
Lead sponsor: National Human Genome Research Institute (NHGRI); NIH
Eligibility: 18 Years and older
Enrollment: 326 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2020
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Newly Diagnosed Glioblastoma
Interventions: Nivolumab, Relatlimab, TMZ, Radiation Therapy; Drug · Radiation
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 3
States / cities: New York, New York • Durham, North Carolina • Houston, Texas

Conditions: PreDiabetes, Prediabetic State, Overweight and Obesity
Interventions: PreventT2 (Individual intervention), PreventT2 Together (Couple-based intervention); Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Urinary Incontinence
Interventions: PureWick® Urine Collection System, UltraFlex™ Self-Adhering Male External Catheter; Device
Lead sponsor: C. R. Bard; Industry
Eligibility: 65 Years and older · Male only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 2
States / cities: Greenacres City, Florida • Hamilton, New Jersey

Conditions: Anaplastic (Malignant) Meningioma, Atypical Meningioma, Grade II Meningioma, Grade III Meningioma, Recurrent Meningioma, Supratentorial Meningioma
Interventions: Bevacizumab, Electric Field Therapy, NovoTTF-200A Device, Quality-of-Life Assessment; Biological · Procedure · Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2026
U.S. locations: 8
States / cities: Santa Monica, California • Miami, Florida • Atlanta, Georgia + 5 more

Conditions: Metabolic Syndrome
Interventions: Group-Based Program, Self-Directed Program; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 618 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 5
States / cities: Aurora, Colorado • Chicago, Illinois • Kansas City, Missouri + 2 more

Conditions: Metastatic Non-Small Cell Lung Cancer, NSCLC, Lung Cancer
Interventions: Trilaciclib, Placebo, Docetaxel; Drug
Lead sponsor: G1 Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 12
States / cities: Phoenix, Arizona • Los Angeles, California • Rancho Mirage, California + 9 more

Conditions: Behavioral and Psychiatric Symptoms of Dementia, Dementia, Caregivers
Interventions: Intervention with Home-Based Caregivers; Other
Lead sponsor: University of Virginia; Other
Eligibility: 50 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Peripheral Neuropathy
Interventions: Manual acupuncture, Electro-acupuncture; Other
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Brain Injuries
Interventions: Medical Nutrition Therapy; Behavioral
Lead sponsor: University of Alabama, Tuscaloosa; Other
Eligibility: 18 Years and older
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Tuscaloosa, Alabama

Conditions: VTE
Interventions: VTE REHABILITATION: High-Caloric Expenditure Exercise Training (HCE) and The Dietary Behavioral Weight Loss Intervention (BWL); Behavioral
Lead sponsor: University of Vermont; Other
Eligibility: 16 Years to 79 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Sedentary Behavior, Physical Inactivity
Interventions: MOV'D (Move Often eVery Day), Fitbit Self-Monitoring; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Stanford, California

Conditions: Parkinson Disease, Parkinson
Interventions: Serious games; Other
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Alzheimer Disease, Sleep Initiation and Maintenance Disorders
Interventions: Walking Program, Light Exposure Program, Combined Education, Walking and Light Exposure Program, Routine Medical Care with Education; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 55 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Depression
Interventions: Positive Thoughts and Actions Program, Individual Support Program; Behavioral
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: Not listed
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: HIV
Interventions: Lenacapavir long-acting, Standard of Care (SOC); Drug · Other
Lead sponsor: Kelley-Ross & Associates, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Alcohol Consumption
Interventions: Control, Goal Support (GS), Coaching for Context-specific Peer Support (CCPS); Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 25 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Diabetes Mellitus, Type 2
Interventions: BT-001, Control App; Behavioral · Other
Lead sponsor: Better Therapeutics; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 3
States / cities: Aurora, Colorado • New Orleans, Louisiana • Durham, North Carolina

Conditions: Allergic Rhinitis, Sinusitis
Interventions: QHSLab Digital Tools (AME and ARIS); Other
Lead sponsor: QHSLab, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: West Palm Beach, Florida

Search by objective public record fields.

Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults

Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting

Establishing the Preliminary Utility of a Novel Pediatric Manual Mobile Standing Wheelchair

A Positive Food Parenting Intervention to Promote Healthy Growth in Children at Risk for Obesity

Digihaler in Chronic Obstructive Pulmonary Disease (COPD)

Patient Provider Communication and Interaction in a Virtual Clinical Setting

Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab

Couple-Based Lifestyle Intervention to Prevent Type 2 Diabetes

This Study Will Collect Clinical and Patient Reported Satisfaction Data From Males Requiring Urine Output Management Overnight in the Home Setting.

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

Enhanced Lifestyles for Metabolic Syndrome

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Docetaxel for Metastatic Non-Small Cell Lung Cancer (NSCLC) (PRESERVE 4)

Behavioral and Environmental Sensing and Intervention

Clinical Trial of Acupuncture for Chemotherapy-Induced Peripheral Neuropathy

The HOME Study (Healthy Options Made Easy): Telehealth Nutrition Sessions for People Living With Brain Injury

Exercise Training After an Acute Blood Clot

Peer Motivation Coaches, Social Media-based Support Group, and Behavior Change Strategies to Decrease Prolonged Sitting and Increase Moderate Exercise Snacks

Serious Games for Parkinson's Disease

Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease

Middle School Matters Study

Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting

Texting to Reduce Alcohol Misuse Pilot Trial

Digital Therapeutic Based Investigation to Improve Glycemic Control in Patients With Type 2 Diabetes and Residual Hyperglycemia on Stable Medical Therapy

Harnessing Digital Medicine to Improve Allergic Rhinitis Management in Primary Care (DMAR)